Thurles on Friday, October 31, as 127 graduates - joined by family, friends and lecturers - gathered for the inaugural MIC Thurles conferring ceremony, the first to be held in the town since MIC’s ...

The Welsh Ambulance Service has appointed two specialist nurses, a midwife and a physiotherapist to improve the care it ...

Vic Tarr on the impact of providing clinical care, symptom management and holistic family support to children with cancer in ...

The fund underperformed the Russell 1000 Value Index. Stock selection in materials, communication services and information technology (IT) detracted from relative return.

Watch: Nara Smith Reveals Dr. Seuss Inspired Name She Almost Gave Baby No. 4 And though Nara herself might not have gotten the chance to use these names herself, she's hoping that others may ...

Let’s begin with a two-year chart showing the movement of gold prices through early Friday: On Tuesday, front-month contract prices for gold GC00 on the New York Mercantile Exchange declined 5.7% to ...

I am including, without complete analysis, a list of ETFs one might want to consider if they are interested in the 50/30/20 investment plan. These are just the top alternative ETFs on my watchlist, ...

You can make money from meme stocks. Not by investing in them, but by doing the opposite. I’m referring to the relatively obscure and illiquid stocks that now and then will capture the attention of ...

The death toll was growing Wednesday as Hurricane Melissa made its way across Cuba and headed for the Bahamas, a day after making landfall in Jamaica as one of the region's strongest storms on record.

When readers became concerned about a straggler sandhill crane at Creamer’s Field this week, some of them recalled years ago when the Alaska Department of Fish & Game rescued an injured crane at the ...

Go ahead and roll your eyes. Shrug your shoulders. Or maybe just juggle your hands in the air. Dictionary.com’s word of the year isn’t even really a word. It’s the viral term “6-7” that kids and ...

CRISPR Therapeutics has an approved gene-editing therapy, Casgevy, which can be a game changer for patients who need it. The company continues to burn through cash, but its financial position remains ...